{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:18:28Z","timestamp":1790774308269,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010747","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000}}],"reference-count":202,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010747.pub2","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T05:37:23Z","timestamp":1535607443000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients"],"prefix":"10.1002","volume":"2018","author":[{"given":"S Fadilah","family":"Abdul Wahid","sequence":"first","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Cell Therapy Center; Jalan Yaacob Latif Kuala Lumpur Malaysia 56000"},{"name":"Universiti Kebangsaan Malaysia Medical Centre; Clinical Haematology & Stem Cell Transplantation Services, Department of Medicine; Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Azimah","family":"Ismail","sequence":"additional","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Cell Therapy Center; Jalan Yaacob Latif Kuala Lumpur Malaysia 56000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Fariza","family":"Wan Jamaludin","sequence":"additional","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Cell Therapy Center; Jalan Yaacob Latif Kuala Lumpur Malaysia 56000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Asiah","family":"Muhamad","sequence":"additional","affiliation":[{"name":"Ministry of Health; Institute for Public Health; Kuala Lumpur Federal Teritory Malaysia 50590"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Khairul Azaham","family":"Abdul Hamid","sequence":"additional","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Cell Therapy Center; Jalan Yaacob Latif Kuala Lumpur Malaysia 56000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanafiah","family":"Harunarashid","sequence":"additional","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Unit of Vascular Surgery, Department of Surgery; Jalan Yaacob Latif Kuala Lumpur Kuala Lumpur Malaysia 56000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai Ming","family":"Lai","sequence":"additional","affiliation":[{"name":"Taylor's University; School of Medicine; Subang Jaya Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD010747.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00029330-200806010-00001","article-title":"Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia","volume":"121","author":"Gu","year":"2008","journal-title":"Chinese Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1160\/TH07-02-0137","article-title":"Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans","volume":"98","author":"Huang","year":"2007","journal-title":"Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD010747.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3727\/096368912X636948","article-title":"No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia","volume":"21","author":"Klepanec","year":"2012","journal-title":"Cell Transplantation"},{"issue":"14","key":"10.1002\/14651858.CD010747.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"E1473","DOI":"10.1016\/S0735-1097(11)61473-3","article-title":"Autologous bone marrow cells transplantation in patients with advanced critical limb ischemia: no difference in intra-arterial and intramuscular application","volume":"57","author":"Madaric","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","article-title":"A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia","volume":"5","author":"Losordo","year":"2012","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0007|cit7","first-page":"51","article-title":"Intramuscular or combined intramuscular\/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia","volume":"49","author":"Tongeren","year":"2008","journal-title":"Journal of Cardiovascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0008|cit8","first-page":"1109","article-title":"Autologous transplantation of bone marrow stem cells versus peripheral blood stem cells for treatment of diabetic lower limb ischemia: a comparative study in 52 cases","volume":"13","author":"Zhang","year":"2009","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"Suppl 88","key":"10.1002\/14651858.CD010747.pub2-BIB0009|cit9","first-page":"59","article-title":"Endothelial progenitor cells as biological marker of peripheral arterial disease","volume":"44","author":"Afan","year":"2015","journal-title":"Vasa-European Journal of Vascular Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1024\/0301-1526.37.4.319","article-title":"Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI)","volume":"37","author":"Amann","year":"2008","journal-title":"VASA. Zeitschrift fur Gefasskrankheiten"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010747.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2482-13-S1-A1","article-title":"Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesis","volume":"12","author":"Amato","year":"2012","journal-title":"BMC Surgery"},{"issue":"9","key":"10.1002\/14651858.CD010747.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1253\/circj.70.1093","article-title":"Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease","volume":"70","author":"Arai","year":"2006","journal-title":"Circulation Journal"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12967-015-0697-4","article-title":"Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients","volume":"13","author":"Arici","year":"2015","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0014|cit14","first-page":"155","article-title":"Bone-marrow cells in therapy of critical limb ischaemia of lower extremities - own experience","volume":"12","author":"Bar\u0107","year":"2006","journal-title":"Acta Angiologica"},{"issue":"12","key":"10.1002\/14651858.CD010747.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00392-007-0569-x","article-title":"Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study)","volume":"96","author":"Bartsch","year":"2007","journal-title":"Clinical Research in Cardiology"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1479-5876-9-165","article-title":"The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design","volume":"9","author":"Benoit","year":"2011","journal-title":"Journal of Translational Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jvs.2011.06.118","article-title":"Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia","volume":"54","author":"Iafrati","year":"2011","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0018|cit18","first-page":"6227","article-title":"Autologous bone marrow mesenchymal stem cell transplantation for treatment of diabetic foot following amplification in vitro","volume":"13","author":"Bing","year":"2009","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcyt.2013.11.011","article-title":"Phase I trial: the use of autologous cultured adipose-derived stroma\/stem cells to treat patients with non-revascularizable critical limb ischemia","volume":"16","author":"Bura","year":"2014","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/bmt.2009.102","article-title":"Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia","volume":"45","author":"Burt","year":"2010","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1423-0410.2008.01138.x","article-title":"Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product","volume":"96","author":"Capiod","year":"2009","journal-title":"Vox Sanguinis"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0022|cit22","first-page":"281","article-title":"Autologous intra-arterial infusion of bone marrow mononuclear cells in patients with critical leg ischemia","volume":"27","author":"Chochola","year":"2008","journal-title":"International Angiology"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0023|cit23","unstructured":"Choi ET Geraghty P Cooke C Schechtman K Link D Chambers CM Veeraswamy RK Stem cell mobilization to treat severe peripheral artery disease (STEMPAD) Vascular Annual Meeting 2012 LB7"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0024|cit24","unstructured":"NCT00797056 Stem cell mobilization by G-CSF to treat severe peripheral artery disease clinicaltrials.gov\/ct2\/show\/NCT00797056"},{"issue":"10","key":"10.1002\/14651858.CD010747.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/bmt.2008.228","article-title":"Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease","volume":"42","author":"Cobellis","year":"2008","journal-title":"Bone Marrow Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD010747.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.transproceed.2010.04.047","article-title":"Successful bone marrow transplantation reveals the lack of endothelial progenitor cells mobilization in a patient with critical limb ischemia: a case report","volume":"42","author":"Cobellis","year":"2010","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12967-017-1243-3","article-title":"Stromal vascular fraction cells for the treatment of critical limb ischemia: a pilot study","volume":"15","author":"Darinskas","year":"2017","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00268-012-1892-6","article-title":"Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study","volume":"37","author":"Das","year":"2013","journal-title":"World Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/rej.2009.0872","article-title":"Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells","volume":"12","author":"Dash","year":"2009","journal-title":"Rejuvenation Research"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/ten.tec.2014.0245","article-title":"Limb rescue: a new autologous-peripheral blood mononuclear cells technology in critical limb ischemia and chronic ulcers","volume":"21","author":"Angelis","year":"2014","journal-title":"Tissue Engineering. Part C, Methods"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1000-1948(08)60031-3","article-title":"Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia","volume":"23","author":"Debin","year":"2008","journal-title":"Journal of Medical Colleges of PLA"},{"issue":"7","key":"10.1002\/14651858.CD010747.pub2-BIB0032|cit32","first-page":"893","article-title":"A follow-up study on autologous bone marrow mononuclear cells transplantation for critical lower arteriosclerosis obliterans in diabetic patients","volume":"29","author":"Dou","year":"2015","journal-title":"Zhongguo Xiu fu Chong Jian Wai ke za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery"},{"issue":"105","key":"10.1002\/14651858.CD010747.pub2-BIB0033|cit33","first-page":"290","article-title":"Stem cell implantation in the treatment of peripheral vascular disease","volume":"Suppl 1","author":"Doudar","year":"2013","journal-title":"Vox Sang"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0034|cit34","first-page":"82","article-title":"Umbilical cord mesenchymal stem cells combined with bone marrow stem cells for treatment of lower limb ischemia","volume":"21","author":"Du","year":"2017","journal-title":"Chinese Journal of Tissue Engineering Research"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/dmrr.2399","article-title":"Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment","volume":"29","author":"Dubsky","year":"2013","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"7","key":"10.1002\/14651858.CD010747.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/modpathol.2008.48","article-title":"Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia","volume":"21","author":"Duong Van Huyen","year":"2008","journal-title":"Modern Pathology"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ymthe.2016.12.019","article-title":"Phase Ib safety, two-odse study of MultiGeneAngio in patients with chronic critical limb ischemia","volume":"25","author":"Flugelman","year":"2017","journal-title":"Molecular Therapy"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jvs.2009.07.113","article-title":"Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease","volume":"50","author":"Franz","year":"2009","journal-title":"Journal of Vascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/1538574411405545","article-title":"Short- to mid-term results using autologous bone-marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease","volume":"45","author":"Franz","year":"2011","journal-title":"Vascular and Endovascular Surgery"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD010747.pub2-BIB0040|cit40","first-page":"88","article-title":"Adult stem\/progenitor cells derived from peripheral blood as a personalized treatment for critical limb ischemia (CLI)","volume":"25","author":"Frogel","year":"2017","journal-title":"Vascular"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0041|cit41","first-page":"197","article-title":"Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial","volume":"9","author":"Gabr","year":"2011","journal-title":"Experimental and Clinical Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1358863X15612148","article-title":"Phase I study of multi-gene cell therapy in patients with peripheral artery disease","volume":"21","author":"Grossman","year":"2016","journal-title":"Vascular Medicine (London, England)"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0043|cit43","first-page":"504","article-title":"Effective autologous bone marrow stem cell dosage for treatment of severe lower limb ischemia","volume":"20","author":"Gu","year":"2006","journal-title":"Zhongguo Xiu fu Chong Jian Wai ke za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery"},{"issue":"7","key":"10.1002\/14651858.CD010747.pub2-BIB0044|cit44","first-page":"675","article-title":"[Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia]","volume":"21","author":"Gu","year":"2007","journal-title":"Zhongguo Xiu fu Chong Jian Wai ke za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"346","DOI":"10.23736\/S0392-9590.16.03796-2","article-title":"Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia","volume":"36","author":"Gu","year":"2017","journal-title":"International Angiology"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13287-018-0784-6","article-title":"Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results","volume":"9","author":"Guo","year":"2018","journal-title":"Stem Cell Research & Therapy"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1479-5876-11-143","article-title":"A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia","volume":"11","author":"Gupta","year":"2013","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.jcyt.2014.01.295","article-title":"Role of bone marrow derived allogeneic mesenchymal stromal cells (Stempeucel) in critical limb ischemia due to Buerger's disease-efficacy and safety results of non-randomized, open label, multicentric, dose ranging, phase II study in India","volume":"16","author":"Gupta","year":"2014","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0050|cit49","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jvs.2017.08.009","article-title":"Administration of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells in critical limb ischemia due to Buerger's disease: phase II study report suggests clinical efficacy","volume":"66","author":"Gupta","year":"2017","journal-title":"Journal of Vascular Surgery"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0049|cit50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.5966\/sctm.2016-0237","article-title":"Administration of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells in critical limb ischemia due to Buerger's disease: phase II study report suggests clinical efficacy","volume":"6","author":"Gupta","year":"2017","journal-title":"Stem Cells Translational Medicine"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD010747.pub2-BIB0051|cit51","first-page":"S21","article-title":"Combination BM-MSC with BM-MNC is better than BM-MNC alone in resolution of large ischemic ulcers: a phase II\/III clinical randomised study","volume":"18","author":"Harunarashid","year":"2016","journal-title":"22nd Annual ISCT Meeting"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"19690","DOI":"10.1038\/srep19690","article-title":"Early results of clinical application of autologous whole bone marrow stem cell transplantation for critical limb ischemia with Buerger's disease","volume":"6","author":"Heo","year":"2016","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.atherosclerosis.2006.08.025","article-title":"Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation","volume":"194","author":"Hernandez","year":"2007","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1002\/14651858.CD010747.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.CIR.0000121427.53291.78","article-title":"Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia","volume":"109","author":"Higashi","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0950-821X(05)80155-0","article-title":"Treatment of non-healing skin ulcers with autologous activated mononuclear cells","volume":"8","author":"Holzinger","year":"1994","journal-title":"European Journal of Vascular Surgery"},{"issue":"8","key":"10.1002\/14651858.CD010747.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1253\/circj.71.1193","article-title":"Quality of life improvement and long-term effects of peripheral blood mononuclear cell transplantation for severe arteriosclerosis obliterans in diabetic patients on dialysis","volume":"71","author":"Hoshino","year":"2007","journal-title":"Circulation Journal"},{"issue":"9","key":"10.1002\/14651858.CD010747.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes","volume":"28","author":"Huang","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0058|cit58","unstructured":"NCT00730561 Hematopoietic stem cell transplantation for the treatment of limb ischemia and diabetic neuropathy clinicaltrials.gov\/ct2\/show\/NCT00730561"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD010747.pub2-BIB0059|cit59","first-page":"47S","article-title":"SS03. Bone marrow aspirate concentrate in critical limb ischemia: results of an abridged prospective randomized pivotal trial in no option CLI","volume":"63","author":"Iafrati","year":"2016","journal-title":"Abstracts of the 2016 Vascular Annual Meeting, The Society for Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCINTERVENTIONS.110.955724","article-title":"Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease","volume":"4","author":"Idei","year":"2011","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"10","key":"10.1002\/14651858.CD010747.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1253\/circj.69.1260","article-title":"Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia","volume":"69","author":"Ishida","year":"2005","journal-title":"Circulation Journal"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2009.08.028","article-title":"Impact of implanted bone marrow progenitor cell composition on limb salvage after cell implantation in patients with critical limb ischemia","volume":"209","author":"Iso","year":"2010","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/kel436","article-title":"Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases","volume":"46","author":"Kamata","year":"2007","journal-title":"Rheumatology (Oxford, England)"},{"issue":"11","key":"10.1002\/14651858.CD010747.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/stem.207","article-title":"Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I\/IIa, multicenter, single-blinded, dose-escalation clinical trial","volume":"27","author":"Kawamoto","year":"2009","journal-title":"Stem Cells"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2012.07.031","article-title":"Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia","volume":"224","author":"Kinoshita","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1742-1241.2011.02886.x","article-title":"Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients","volume":"66","author":"Kirana","year":"2012","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0067|cit67","unstructured":"NCT01065337 Induced wound healing by application of expanded bone marrow stem cells in diabetic patients with critical limb ischemia clinicaltrials.gov\/ct2\/show\/NCT01065337 (first received 9 February 200)"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.avsg.2009.07.018","article-title":"Intraoperative adjunctive stem cell treatment in patients with critical limb ischemia using a novel point-of-care device","volume":"24","author":"Kolvenbach","year":"2010","journal-title":"Annals of Vascular Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010747.pub2-BIB0069|cit69","first-page":"A18595","article-title":"Therapeutic angiogenesis for critical limb ischemia by implantation of autologous adipose-derived regenerative cells: a clinical pilot study","volume":"134","author":"Kondo","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1253\/circj.CJ-17-0510","article-title":"Long-term clinical outcomes survey of bone marrow-derived cell therapy in critical limb ischemia in Japan","volume":"82","author":"Kondo","year":"2018","journal-title":"Circulation Journal"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.avsg.2009.10.012","article-title":"Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia","volume":"24","author":"Lara-Hernandez","year":"2010","journal-title":"Annals of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/0003319710364213","article-title":"Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis","volume":"61","author":"Lasala","year":"2010","journal-title":"Angiology"},{"issue":"7","key":"10.1002\/14651858.CD010747.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1253\/circj.CJ-11-1135","article-title":"Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study","volume":"76","author":"Lee","year":"2012","journal-title":"Circulation Journal"},{"issue":"18","key":"10.1002\/14651858.CD010747.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/eurheartj\/ehi285","article-title":"Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia","volume":"26","author":"Lenk","year":"2005","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.6002\/ect.2012.0129","article-title":"Autologous bone marrow mononuclear cells transplant in patients with critical leg ischemia: preliminary clinical results","volume":"11","author":"Li","year":"2013","journal-title":"Experimental and Clinical Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13287-016-0379-z","article-title":"Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia","volume":"7","author":"Madaric","year":"2016","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13287-017-0622-2","article-title":"Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia","volume":"8","author":"Madaric","year":"2017","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.transproceed.2012.10.031","article-title":"Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia","volume":"45","author":"Maione","year":"2013","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0079|cit79","doi-asserted-by":"crossref","unstructured":"Majumdar AS Balasubramanian S Thej C Rajkumar M Krishna M Dutta S A first of its kind phase II clinical trial in critical limb ischemia patients using bone marrow derived, pooled, allogeneic mesenchymal stromal cells (Stempeucel) Cytotherapy 2015 S84","DOI":"10.1016\/j.jcyt.2015.03.601"},{"issue":"9","key":"10.1002\/14651858.CD010747.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jcyt.2014.05.001","article-title":"Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters","volume":"16","author":"Malyar","year":"2014","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0081|cit81","first-page":"233","article-title":"Long-term clinical outcome after intramuscular implantation of bone barrow mononuclear cells (therapeutic angiogenesis by cell transplantation [TACT] Trial) in patients with chronic limb ischemia","volume":"50","author":"Matoba","year":"2009","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"155-61","DOI":"10.1007\/s00547-003-0977-3","article-title":"Therapeutic angiogenesis by transplantation of autologous bone marrow and peripheral blood mononuclear cells in patients with peripheral arterial disease","volume":"12","author":"Matsui","year":"2003","journal-title":"International Journal of Angiology"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/j.jcyt.2017.02.294","article-title":"Autologous mesenchymal stem cells as a novel therapy for no-option critical limb ischemia: preliminary results of a phase 1 study","volume":"19","author":"Mohamed","year":"2017","journal-title":"Cytotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010747.pub2-BIB0084|cit84","first-page":"S82","article-title":"Autologous mesenchymal stem cells as a novel therapy for no-option critical limb ischemia: preliminary results of a phase 1 study","volume":"186","author":"Mohamed","year":"2017","journal-title":"Irish Journal of Medical Science"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-0032-1311646","article-title":"Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia","volume":"121","author":"Mohammadzadeh","year":"2013","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCINTERVENTIONS.108.799361","article-title":"Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia","volume":"2","author":"Moriya","year":"2009","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD010747.pub2-BIB0087|cit87","first-page":"53S-60S; discus","article-title":"Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells","volume":"48","author":"Motukuru","year":"2008","journal-title":"Journal of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jvs.2011.01.074","article-title":"Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia","volume":"53","author":"Murphy","year":"2011","journal-title":"Journal of Vascular Surgery"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD010747.pub2-BIB0089|cit89","first-page":"131S","article-title":"Intramuscular injection of autologous bone marrow cells to prevent amputation in critical limb ischemia: the results of the phase III MOBILE trial","volume":"65","author":"Murphy","year":"2017","journal-title":"Abstracts of the 2017 Vascular Annual Meeting"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/HJR.0b013e3283193a0f","article-title":"Beneficial effects of autologous bone marrow cell infusion and antioxidants\/L-arginine in patients with chronic critical limb ischemia","volume":"15","author":"Napoli","year":"2008","journal-title":"European Journal of Cardiovascular Prevention and Rehabilitation"},{"issue":"7","key":"10.1002\/14651858.CD010747.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.transproceed.2010.04.047","article-title":"Successful bone marrow transplantation reveals the lack of endothelial progenitor cells mobilization in a patient with critical limb ischemia: a case report","volume":"42","author":"Cobellis","year":"2010","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.transproceed.2012.10.031","article-title":"Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia","volume":"45","author":"Maione","year":"2013","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0093|cit93","unstructured":"NCT00306085 Autologous bone marrow cell treatment in peripheral atherosclerosis clinicaltrials.gov\/ct2\/show\/study\/NCT00306085"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/HJR.0b013e3283193a0f","article-title":"Beneficial effects of autologous bone marrow cell infusion and antioxidants\/L-arginine in patients with chronic critical limb ischemia","volume":"15","author":"Napoli","year":"2008","journal-title":"European Journal of Cardiovascular Prevention and Rehabilitation"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0095|cit95","unstructured":"NCT00434616 Autologous bone marrow stem cell transplantation for critical, limb-threatening ischemia (BONMOT) clinicaltrials.gov\/ct2\/show\/NCT00434616"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0096|cit96","unstructured":"NCT00539266 Autologous bone marrow-derived mononuclear cells for therapeutic arteriogenesis in patients with limb ischemia (ABC) clinicaltrials.gov\/ct2\/show\/NCT00539266 (first received October 2007)"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0097|cit97","unstructured":"NCT00922389 A clinical trial on diabetic foot using peripheral blood derived stem cells for treating critical limb ischemia clinicaltrials.gov\/ct2\/show\/NCT00922389"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0098|cit98","unstructured":"NCT01049919 Safety and efficacy study of autologous concentrated bone marrow aspirate (cBMA) for critical limb ischemia (CLI) (MOBILE) clinicaltrials.gov\/ct2\/show\/NCT01049919"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0099|cit99","unstructured":"NCT01245335 Bone marrow aspirate concentrate (BMAC) for treatment of critical limb ischemia (CLI) clinicaltrials.gov\/ct2\/show\/NCT01245335"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0100|cit100","unstructured":"NCT01584986 Autologous angiogenic cell precursors (ACPs) for the treatment of peripheral artery disease clinicaltrials.gov\/ct2\/show\/NCT01584986"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0101|cit101","unstructured":"NCT02336646 Cell therapy with mesenchymal stem cell in ischemic limb disease clinicaltrials.gov\/ct2\/show\/NCT02336646"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0102|cit102","unstructured":"NCT03174522 The efficacy and safety of Rexmyelocel-T to treat ischemic ulcers in subjects with CLI Rutherford category 5 and DM clinicaltrials.gov\/ct2\/show\/NCT03174522"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0103|cit103","unstructured":"NCT03214887 Autologous BMMNC combined with HA therapy for PAOD clinicaltrials.gov\/ct2\/show\/NCT03214887"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0104|cit104","unstructured":"NCT03304821 Granulocyte-macrophage stimulating factor (GM-CSF) in peripheral arterial disease clinicaltrials.gov\/ct2\/show\/NCT03304821"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0105|cit105","unstructured":"NCT03339973 Allogeneic ABCB5-positive stem cells for treatment of PAOD clinicaltrials.gov\/ct2\/show\/NCT03339973"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0106|cit106","doi-asserted-by":"crossref","unstructured":"Nemcova A Jirkovska A Dubsky M Bem R Fejfarova V Pysna A Serum levels of angiogenic cytokines in the assessment of vasculogenesis after autologous cell therapy in diabetic patients with critical limb ischaemia Diabetologia 2017 S468","DOI":"10.33549\/physiolres.933868"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0107|cit107","unstructured":"Niven MJ Sivak G Kafri E Moshe M Galili O Frogel M Adult stem\/progenitor cells as a personalised treatment for peripheral vascular disease Diabetologia 2017 S31"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0108|cit108","first-page":"351-60; discuss","article-title":"The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation","volume":"63","author":"Nizankowski","year":"2005","journal-title":"Kardiologia Polska"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"iii309","DOI":"10.1093\/ndt\/gfx152.SP534","article-title":"Effect of autologous G-CSF-mobilized CD34+ cell transplantation in hemodialysis patients with critical limb ischemia","volume":"32(Suppl 3)","author":"Ohtake","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bmt.2010.110","article-title":"Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis","volume":"46","author":"Onodera","year":"2011","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jdiacomp.2011.11.007","article-title":"Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia","volume":"26","author":"Ozturk","year":"2012","journal-title":"Journal of Diabetes and Its Complications"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejvs.2015.09.010","article-title":"Quality of life after treatment with autologous bone marrow derived cells in no option severe limb ischemia","volume":"51","author":"Peeters Weem","year":"2016","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"7","key":"10.1002\/14651858.CD010747.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ccd.23066","article-title":"A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia","volume":"78","author":"Perin","year":"2011","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ahj.2014.07.021","article-title":"Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells","volume":"168","author":"Perin","year":"2014","journal-title":"American Heart Journal"},{"issue":"15","key":"10.1002\/14651858.CD010747.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.116.025707","article-title":"Evaluation of cell therapy on exercise performance and limb perfusion in peripheral artery disease: the CCTRN PACE Trial (patients with intermittent claudication injected with ALDH bright cells)","volume":"135","author":"Perin","year":"2017","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0116|cit116","unstructured":"NCT00904501 Bone marrow autograft in limb ischemia (BALI) clinicaltrials.gov\/ct2\/show\/study\/NCT00904501"},{"issue":"11","key":"10.1002\/14651858.CD010747.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1253\/circj.CJ-17-0045","article-title":"Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia: results of a randomized, double-blind, placebo-controlled trial","volume":"81","author":"Pignon","year":"2017","journal-title":"Circulation Journal"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"4137626","DOI":"10.1155\/2017\/4137626","article-title":"Safety and effectiveness of bone marrow cell concentrate in the treatment of chronic critical limb ischemia utilizing a rapid point-of-care system","volume":"2017","author":"Ponemone","year":"2017","journal-title":"Stem Cells International"},{"issue":"24","key":"10.1002\/14651858.CD010747.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1001\/jama.2013.282540","article-title":"Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial","volume":"310","author":"Poole","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","article-title":"Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial","volume":"20","author":"Powell","year":"2012","journal-title":"Molecular Therapy"},{"issue":"11","key":"10.1002\/14651858.CD010747.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3727\/096368910X514170","article-title":"Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer","volume":"19","author":"Prochazka","year":"2010","journal-title":"Cell Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0002-8703(03)00102-9","article-title":"Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: design of the RAVE trial","volume":"145","author":"Rajagopalan","year":"2003","journal-title":"American Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD010747.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3727\/096368910X0177","article-title":"Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia","volume":"20","author":"Ruiz-Salmeron","year":"2011","journal-title":"Cell Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD010747.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1253\/circj.71.1187","article-title":"Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease","volume":"71","author":"Saito","year":"2007","journal-title":"Circulation Journal"},{"issue":"7","key":"10.1002\/14651858.CD010747.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.5966\/sctm.2012-0021","article-title":"A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study","volume":"1","author":"Schiavetta","year":"2012","journal-title":"Stem Cells Translational Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/14653249.2011.627917","article-title":"Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia","volume":"14","author":"Smadja","year":"2012","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ahj.2009.04.014","article-title":"Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease","volume":"158","author":"Subramaniyam","year":"2009","journal-title":"American Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD010747.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jcyt.2013.05.017","article-title":"Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease - results of the short- and long-term follow-up","volume":"15","author":"Szabo","year":"2013","journal-title":"Cytotherapy"},{"issue":"21-22","key":"10.1002\/14651858.CD010747.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1089\/ten.tea.2010.0525","article-title":"Controlled-release basic fibroblast growth factor for peripheral artery disease: comparison with autologous bone marrow-derived stem cell transfer","volume":"17","author":"Takagi","year":"2011","journal-title":"Tissue Engineering. Part A"},{"issue":"9331","key":"10.1002\/14651858.CD010747.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/CIRCRESAHA.114.302791","article-title":"Bone marrow microvascular and neuropathic alterations in patients with critical limb ischemia","volume":"114","author":"Teraa","year":"2014","journal-title":"Circulation Research"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jvs.2010.02.020","article-title":"Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia","volume":"51","author":"Sprengers","year":"2010","journal-title":"Journal of Vascular Surgery"},{"issue":"10","key":"10.1002\/14651858.CD010747.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","article-title":"Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled rejuvenating endothelial progenitor cells via transcutaneous intra-arterial supplementation (JUVENTAS) trial","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD010747.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1111\/trf.13203","article-title":"Critical limb ischemia: thrombogenic evaluation of two autologous cell therapy products and biologic profile in treated patients","volume":"55","author":"Tournois","year":"2015","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0135|cit135","unstructured":"NCT00282646 Safety and feasibility study of autologous bone marrow cell transplantation in patients with PAOD clinicaltrials.gov\/ct2\/show\/study\/NCT00282646"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCINTERVENTIONS.110.958348","article-title":"Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"4","author":"Walter","year":"2011","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.avsg.2014.03.002","article-title":"Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia","volume":"28","author":"Wang","year":"2014","journal-title":"Annals of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.1016\/j.jvs.2017.03.210","article-title":"Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared to Caucasians","volume":"65","author":"Wang","year":"2017","journal-title":"Journal of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jvs.2017.01.054","article-title":"Rationale and design of the MarrowStim PAD Kit for the treatment of critical limb ischemia in subjects with severe peripheral arterial disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia","volume":"65","author":"Wang","year":"2017","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jvs.2017.09.057","article-title":"Rationale and design of the Clinical and Histologic Analysis of Mesenchymal stromal cells in amPutations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia","volume":"68","author":"Wang","year":"2018","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/145749690809700108","article-title":"Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study","volume":"97","author":"Wester","year":"2008","journal-title":"Scandinavian Journal of Surgery"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0142|cit142","unstructured":"NCT03042572 Allogeneic mesenchymal stromal cells for angiogenesis and neovascularization in no-option ischemic limbs (SAIL) clinicaltrials.gov\/ct2\/show\/NCT03042572"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jvs.2017.09.026","article-title":"Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia","volume":"67","author":"Wijnand","year":"2018","journal-title":"Journal of Vascular Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010747.pub2-BIB0144|cit144","first-page":"1080","article-title":"Long-term clinical outcome of therapeutic angiogenesis by cell transplantation in patients with critical limb ischemia","volume":"38","author":"Yanishi","year":"2017","journal-title":"European Heart Journal."},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/14653240903518163","article-title":"Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia","volume":"12","author":"Zafarghandi","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"6925357","DOI":"10.1155\/2016\/6925357","article-title":"Transcatheter arterial infusion of autologous CD133(+) cells for diabetic peripheral artery disease","volume":"2016","author":"Zhang","year":"2016","journal-title":"Stem Cells International"},{"issue":"8","key":"10.1002\/14651858.CD010747.pub2-BIB0147|cit147","first-page":"1464","article-title":"Combined transplantation of autologous peripheral blood and bone marrow stem cells for the treatment of diabetic lower limb ischaemia: randomized controlled trial. [Chinese]","volume":"12","author":"Zhao","year":"2008","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0148|cit148","first-page":"5177","article-title":"Efficacy, safety and influencing factors of intra-calf muscular injection of bone marrow mononuclear cells in the treatment of type 2 diabetes mellitus-induced lower extremity vascular disease","volume":"14","author":"Zhou","year":"2017","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"13","key":"10.1002\/14651858.CD010747.pub2-BIB0149|cit149","first-page":"1998","article-title":"Autologous CD34+ cell transplantation promotes angiogenesis in older adult patients with atherosclerotic ischemia: study protocol for a prospective, single-center, open-label, randomized controlled clinical trial","volume":"21","author":"Zhou","year":"2017","journal-title":"Chinese Journal of Tissue Engineering Research"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0150|cit150","unstructured":"Gurunathan Mani S Raju R Kuppu Sampath V Multicentre randomised clinical trial on the role of autologous bone-marrow aspirate-concentrate (BMAC)\/CD34\/(EPC) in non-reconstructable critically ischaemic limbs The Vascular Society of Great Britain & Ireland Yearbook 2009 2009 56"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0151|cit151","first-page":"28","article-title":"Use of autologous progenitor cells of the bone marrow in treatment of patients with lower-limb atherosclerosis obliterans","volume":"15","author":"Korymasov","year":"2009","journal-title":"Angiologiia i Sosudistaia Khirurgiia = Angiology and Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0152|cit152","first-page":"388","article-title":"Safety and efficacy of repeated bone marrow mononuclear cell therapy in patients with critical limb ischemia in a pilot randomized controlled trial","volume":"19","author":"Molavi","year":"2016","journal-title":"Archives of Iranian Medicine"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0153|cit153","unstructured":"NCT01480414 Side effects of 4 times bone marrow mononuclear transplantation in patients with ischemic lower limb clinicaltrials.gov\/ct2\/show\/NCT01480414"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0154|cit154","unstructured":"NCT00595257 Feasibility study of autologous bone marrow aspirate concentrate for treatment of CLI clinicaltrials.gov\/ct2\/show\/study\/NCT00595257"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0155|cit155","unstructured":"NCT00987363 Intraarterial infusion of autologous bone marrow in diabetic patients with chronic ischemia of lower limbs (CLI) no revascularization clinicaltrials.gov\/ct2\/show\/study\/NCT00987363"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0156|cit156","unstructured":"NCT02993809 Autologous transplantation of BM-ECs with platelet-rich plasma extract for the treatment of critical limb ischemia clinicaltrials.gov\/ct2\/show\/study\/NCT02993809"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0157|cit157","unstructured":"NCT00311805 Autologous CD34+ stem cell injection for severe intermittent claudication (leg pain) clinicaltrials.gov\/ct2\/show\/study\/NCT00311805"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0158|cit158","unstructured":"NCT00753025 Autologous bone marrow for lower extremity ischemia treating clinicaltrials.gov\/ct2\/show\/study\/NCT00753025"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0159|cit159","unstructured":"NCT01257776 Human adipose derived mesenchymal stem cells for critical limb ischemia (CLI) in diabetic patients clinicaltrials.gov\/ct2\/show\/study\/NCT01257776"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0160|cit160","unstructured":"NCT01408381 Intra-arterial infusion of autologous bone marrow mononuclear cells in non-diabetic patients with critical limb ischemia (CLI) clinicaltrials.gov\/ct2\/show\/study\/NCT01408381"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0161|cit161","unstructured":"NCT01446055 Safety and efficacy study of autologous BM-MNC processed by two methods for treating patients with chronic limb ischemia clinicaltrials.gov\/ct2\/show\/study\/NCT01446055"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0162|cit162","unstructured":"NCT01745744 Application of cell regeneration therapy with mesenchymal stem cells from adipose tissue in critical chronic ischemic syndrome of lower limbs (CLI) in nondiabetic patients clinicaltrials.gov\/ct2\/show\/study\/NCT01745744"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0163|cit163","unstructured":"NCT02454231 Monocentric trial: stem cell emergency life threatening limbs arteriopathy (SCELTA) clinicaltrials.gov\/ct2\/show\/NCT02454231"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3727\/096368912X636777","article-title":"Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review","volume":"22","author":"Benoit","year":"2013","journal-title":"Cell Transplantation"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0165|cit165","first-page":"5","article-title":"Autologous bone marrow cell therapy for peripheral arterial disease","volume":"5","author":"Botti","year":"2012","journal-title":"Stem Cells and Cloning: Advances and Applications"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jvs.2010.10.088","article-title":"Endovascular management of patients with critical limb ischemia","volume":"53","author":"Conrad","year":"2011","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0167|cit167","unstructured":"Deeks JJ Higgins JPT Altman DG editor(s) Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD010747.pub2-BIB0168|cit168","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"Journal of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clinimag.2006.07.002","article-title":"Standard-protocol moving-table magnetic resonance angiography for planning of interventional procedures in patients with peripheral vascular occlusive disease","volume":"30","author":"Drescher","year":"2006","journal-title":"Clinical Imaging"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jvs.2006.06.023","article-title":"Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans","volume":"44","author":"Durdu","year":"2006","journal-title":"Journal of Vascular Surgery"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.transci.2013.07.032","article-title":"Predictors of the yield of mobilized peripheral blood CD34+ cells in HLA-matched sibling donor","volume":"49","author":"Fadilah","year":"2013","journal-title":"Transfusion and Apheresis Science"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2007.03.046","article-title":"Endothelial progenitor cells in the natural history of atherosclerosis","volume":"194","author":"Fadini","year":"2007","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","article-title":"Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature","volume":"209","author":"Fadini","year":"2010","journal-title":"Atherosclerosis"},{"issue":"21","key":"10.1002\/14651858.CD010747.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1001\/jama.1993.03510210084032","article-title":"Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group","volume":"270","author":"Guyatt","year":"1993","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0175|cit175","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated 2011). The Cochrane Collaboration 2011 Available from handbook.cochrane.org"},{"issue":"10","key":"10.1002\/14651858.CD010747.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1161\/01.ATV.0000240248.55172.dd","article-title":"Effects of granulocyte colony stimulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease","volume":"26","author":"Honold","year":"2006","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1160\/TH03-06-0343","article-title":"Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities","volume":"91","author":"Huang","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"issue":"9350","key":"10.1002\/14651858.CD010747.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(02)11976-3","article-title":"Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis?","volume":"360","author":"Inaba","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/CIRCRESAHA.109.213140","article-title":"The promise of cell-based therapies for diabetic complications challenges and solutions","volume":"106","author":"Jarajapu","year":"2010","journal-title":"Circulation Research"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Molecular Cell"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10047-006-0351-2","article-title":"Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs","volume":"9","author":"Kawamura","year":"2006","journal-title":"Journal of Artificial Organs"},{"issue":"5","key":"10.1002\/14651858.CD010747.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0003319715595172","article-title":"Cell therapy for critical limb ischemia: a meta-analysis of randomized controlled trials","volume":"67","author":"Liew","year":"2016","journal-title":"Angiology"},{"issue":"23","key":"10.1002\/14651858.CD010747.pub2-BIB0183|cit183","first-page":"4296","article-title":"Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of randomized controlled trials","volume":"125","author":"Liu","year":"2012","journal-title":"Chinese Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD010747.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"e0125032","DOI":"10.1371\/journal.pone.0125032","article-title":"Therapeutic efficacy of stem cell-based therapy in peripheral arterial disease: a meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PloS One"},{"issue":"24","key":"10.1002\/14651858.CD010747.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1161\/CIRCULATIONAHA.106.644203","article-title":"Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans","volume":"114","author":"Miyamoto","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD010747.pub2-BIB0186|cit186","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008347.pub3","article-title":"Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia","author":"Moazzami","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0187|cit187","unstructured":"National Guideline Clearinghouse (NGC) Lower limb peripheral arterial disease: diagnosis and management National Institute for Health and Clinical Excellence (NICE)"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45(Suppl S)","author":"Norgren","year":"2007","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejvs.2010.05.005","article-title":"The next 10 years in the management of peripheral artery disease: Perspectives from the 'PAD 2009' conference","volume":"40","author":"Norgren","year":"2010","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"5411","key":"10.1002\/14651858.CD010747.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"12","key":"10.1002\/14651858.CD010747.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.jcyt.2014.07.011","article-title":"Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial","volume":"16","author":"Raval","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0192|cit192","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"3","key":"10.1002\/14651858.CD010747.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI0214327","article-title":"Origin of endothelial progenitors in human postnatal bone marrow","volume":"109","author":"Reyes","year":"2002","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1002\/14651858.CD010747.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1078-5884(97)80017-2","article-title":"Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience","volume":"13","author":"Sasajima","year":"1997","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD010747.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ar.a.10131","article-title":"Hemangioblasts, angioblasts, and adult endothelial cell progenitors","volume":"276","author":"Schatteman","year":"2004","journal-title":"The Anatomical Record Part A. Discoveries in Molecular, Cellular, and Evolutionary Biology"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0196|cit196","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P on behalf of the Cochrane Applicability and Recommendations Methods Group Chapter 12. Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0197|cit197","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group Chapter 11. Presenting results and \u2018Summary of findings\u2019 tables. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD010747.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4236\/jbise.2014.72011","article-title":"Critical appraisal of stem cell therapy in peripheral arterial disease: do current scientific breakthroughs offer true promise or false hope?","volume":"7","author":"Sultan","year":"2014","journal-title":"Journal of Biomedical Science and Engineering"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0199|cit199","first-page":"8740","article-title":"Meta-analysis on autologous stem cell transplantation in the treatment of limb ischemia","volume":"8","author":"Sun","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010747.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Annals of Surgery"},{"issue":"12","key":"10.1002\/14651858.CD010747.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1517\/14712598.2011.626401","article-title":"Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials","volume":"11","author":"Wen","year":"2011","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"9","key":"10.1002\/14651858.CD010747.pub2-BIB0202|cit202","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010747","article-title":"Different sources of autologous mononuclear cells and stem cells for critical lower limb ischaemia","author":"Abdul Wahid","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010747.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T08:33:54Z","timestamp":1673944434000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010747.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":202,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010747.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]}}}